4//SEC Filing
Foster-Cheek Kaye I 4
Accession 0001439222-24-000105
CIK 0001439222other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:10 PM ET
Size
7.8 KB
Accession
0001439222-24-000105
Insider Transaction Report
Form 4
Foster-Cheek Kaye I
Director
Transactions
- Award
Stock options (right to buy)
2024-06-20+11,774→ 11,774 totalExercise: $42.45Exp: 2034-06-20→ Common stock (11,774 underlying) - Award
Restricted stock units
2024-06-20+2,120→ 2,120 total→ Common stock (2,120 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on June 20, 2024. The shares underlying the stock units will vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
- [F3]This option was granted on June 20, 2024. The shares underlying this option vest as to 100% of the underlying shares on June 20, 2025.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001312622
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:10 PM ET
- Size
- 7.8 KB